A comprehensive analysis of peptides presented by HLA-A1

Tissue Antigens

Volumn 85, Issue 6, 2015, Pages 492-496

  Giam, K ^a,b   Ayala Perez, R ^a   Illing, P T ^a   Schittenhelm, R B ^a   Croft, N P ^a   Purcell, A W ^a   Dudek, N L ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen presentation; Human leukocyte antigen A1; Immunopeptidome; Mass spectrometry; Peptides

Indexed keywords

AMINO ACID; HLA A1 ANTIGEN; LIGAND; HLA-A*01:01 ANTIGEN; PEPTIDE; RECOMBINANT PROTEIN;

ALGORITHM; ALLELE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CAUCASIAN; GENE IDENTIFICATION; HLA A 01:01 GENE; HUMAN; HUMAN CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN MOTIF; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; B LYMPHOCYTE; CHEMISTRY; GENETIC TRANSFECTION; IMMUNOLOGY; TRANSFORMED CELL LINE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; HLA-A1 ANTIGEN; HUMANS; LIGANDS; PEPTIDES; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 84929043164     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12565     Document Type: Article

References (20)

1. Falk K et al. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 1994: 40: 238-41.
2. *04:01 (Cw4)-specific peptides. Tissue Antigens 2014: 83: 174-9.
3. Neefjes J et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011: 11: 823-36.
4. Saunders PM, van Endert P. Running the gauntlet: from peptide generation to antigen presentation by MHC class I. Tissue Antigens 2011: 78: 161-70.
5. Reche PA, Reinherz EL. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 2003: 331: 623-41.
6. Macdonald WA et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 2003: 198: 679-91.
7. Archbold JK et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med 2009: 206: 209-19.
8. Illing PT et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012: 486: 554-8.
9. Zernich D et al. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med 2004: 200: 13-24.
10. Moore CB et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002: 296: 1439-43.
11. Limou S et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009: 199: 419-26.
12. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007: 6: 404-14.
13. Mester G, Hoffmann V, Stevanovic S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci 2011: 68: 1521-32.
14. *02:01 ligands. Mol Immunol 2012: 51: 136-42.
15. Dudek NL et al. Constitutive and inflammatory immunopeptidome of pancreatic beta-cells. Diabetes 2012: 61: 3018-25.
16. Kubo RT et al. Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 1994: 152: 3913-24.
17. de Castro JAL et al. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 2004: 63: 424-45.
18. Schittenhelm RB et al. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheumatol 2014: 67: 702-13.
19. *39:06. Tissue Antigens 2014: 84: 378-88.
20. Gonzalez-Galarza FF et al. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011: 39 (Database issue): D913-9.